Clinical trials
Phase 1 Mouth Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 1 |
| 2025 | 6 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Recruiting | 9 |
| Terminated | 8 |
| Active, not recruiting | 7 |
| Unknown status | 4 |
| Withdrawn | 3 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 7 |
| M.D. Anderson Cancer Center | 6 |
| Vanderbilt-Ingram Cancer Center | 3 |
| Erasmus Medical Center | 2 |
| Roswell Park Cancer Institute | 2 |
| Shanghai Jiao Tong University School of Medicine | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Brian Henick, MD | 1 |
| British Columbia Cancer Agency | 1 |
| Cairo University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mouth Neoplasms | 49 |
| Head and Neck Neoplasms | 24 |
| Oropharyngeal Neoplasms | 18 |
| Laryngeal Neoplasms | 17 |
| Hypopharyngeal Neoplasms | 15 |
| Squamous Cell Carcinoma of Head and Neck | 13 |
| Breast Neoplasms | 9 |
| Lung Neoplasms | 7 |
| Carcinoma | 6 |
| Carcinoma, Squamous Cell | 6 |
Trials
Showing 26 to 49 of 49. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.